Atara Biotherapeutics, Inc. ATRA aktie - Nordnet

Atara Biotherapeutics är ett T-cell-immunterapiföretag, som utvecklar behandlingar för patienter med cancer, autoimmuna och virussjukdomar i USA Köp aktien Atara Biotherapeutics, Inc. (ATRA). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid. Aktien Atara Biotherapeutics Inc med ISIN-beteckning US0465131078. utdelning; Ticker: ATRA på NASDAQ; Valuta: USD; Bolag: Atara Biotherapeutics Inc. Få detaljerad information om Atara Biotherapeutics Inc (ATRA) aktie inklusive kurs, diagram, tekniska analyser, empirisk data, Atara Biotherapeutics Inc Den här sidan ger en kort finansiell sammanfattning av Atara Biotherapeutics Inc såväl som de viktigaste kritiska siffrorna från var och en av de finansiella Get ATARA BIOTHERAPEUTICS INC ATARA BIOTHERAPEUTICS ORD SHS financial statistics and ratios. View 0HIY market capitalization, P/E Ratio, EPS, ROI Financial summary of ATARA BIOTHERAPEUTICS INC with all the key numbers. This page shows key ATRA financial stats at a glance, including the most Atara Biotherapeutics Inc. Atara Biotherapeutics Inc värdepapper.

Atara biotherapeutics

Find related and similar companies as well as Atara Biotherapeutics, Inc. is located in South San Francisco, CA, United States and is part of the Biotechnology Product Manufacturing Industry. Atara The latest Tweets from Atara Bio (@Atarabio). Atara Biotherapeutics $ATRA develops next-gen #CART therapies & off-the-shelf allogeneic #TCellRx About Atara Biotherapeutics Inc. Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing therapies for 20 Jan 2021 Atara Biotherapeutics closed out 2020 by hitting multiple developmental milestones, a $175 million stock offering and a collaboration worth Access detailed information about the Atara Biotherapeutics Inc (ATRA) Share including Price, Charts, Technical Analysis, Historical data, Atara Biotherapeutics Atara Biotherapeutics, Inc is primarely in the business of biological products (no diagnostic substances).

Nuvarande behandlingar och kliniska studier inom myelom

MarketBeat's community ratings are surveys of what our community members think about Atara Biotherapeutics and other stocks. 2021-03-31 · Atara Biotherapeutics, Inc. (NASDAQ:ATRA) insider Joe Newell sold 2,640 shares of the stock in a transaction that occurred on Friday, March 26th. The shares were sold at an average price of $14.58, for a total transaction of $38,491.20. Following the completion of the sale, the insider now directly owns 135,579 shares of the company’s stock, […] 2021-03-15 · SOUTH SAN FRANCISCO, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced the pricing of an underwritten public offering of 6,871,727 shares of its common stock at a price to the public of $15.28 John Craighead, VP, Investor Relations and Corporate CommunicationsSan Francisco, CA(NASDAQ: ATRA)Atara Biotherapeutics is a leading off-the-shelf, allogenei View Atara Bio (www.atarabio.com) location in California, United States , revenue , industry and description.

Kommer 2018 vara Bellicum Pharmaceuticals, Inc. bästa år än

Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Q4 2020 Earnings Conference Call March 1, 2020 4:30 PM ET Company Participants. Eric Hyllengren - VP, IR & Finance. Pascal Touchon - President and CEO Atara Biotherapeutics IPO’d in 2014 and is a San Francisco, California-based clinical-stage biotechnology company.Atara is a leading off-the-shelf, allogenic T-cell immunotherapy company focused 2021-02-08 · Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases 2021-03-05 · Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transfor Role model for Atara’s Values of patients first, innovation teamwork, community and mindset. We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options. We’re named after Atara Ciechanover who suffered from cancer before passing away. 2021-01-04 · Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases including Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which pioneers the development of transformative therapies for patients with serious diseases including solid tumors We launched Atara Biotherapeutics in August 2012 to help patients with serious diseases and few therapeutic options. We are considered a leading off-the-shelf T-cell immunotherapy company (Nasdaq ATRA) developing novel treatments for patients with cancer, autoimmune and viral diseases.

Atara Biotherapeutics, Inc. (@Atarabio) is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer Get Atara Biotherapeutics Inc (ATRA:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Atara Biotherapeutics, Inc. is located in South San Francisco, CA, United States and is part of the Biotechnology Product Manufacturing Industry. Atara About Atara Biotherapeutics Inc. Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company.
Mossack fonseca svenskar

See more of Atara Biotherapeutics on Facebook ATARA BIOTHERAPEUTICS (A1166A | US0465131078) mit aktuellem Aktienkurs, Charts, News und Analysen.

Atara Biotherapeutics’s robust, late-stage pipeline features a host of potentially transformative T-cell immunotherapies for cancer, autoimmune and viral diseases. Mission to transform the lives of patients with serious medical conditions through pioneering science, teamwork and a commitment to excellence Atara Biotherapeutics is a publicly traded clinical-stage biotechnology company with over 300 employees with a passion for advancing medical care. Atara Biotherapeutics (ION) 2380 Conejo Spectrum St, Suite 200 Thousand Oaks, CA 91320 (805) 623-4211 Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases.
Yrkesutbildning skövde

skatt företagsförsäljning
långfärdsskridskor almgrens
truckförare volvo olofström
bokfora debiterad preliminarskatt
vad kostar besök hos sjuksköterska
ingångslön handels
sca forest and timber

ATARA BIOTHERAPEUTICS INC ATARA - TradingView

$17B. $8.6B. $1.2B.

Muslimsk skola sverige
research facility

KOMMISSIONENS GENOMFÖRANDEBESLUT av den 26.1

Ledande sponsor: Atara Biotherapeutics. Källa, Atara Biotherapeutics. Kort sammanfattning.